Work

Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients

Year: 2013

Type: article

Source: Cardiovascular & Haematological Disorders - Drug Targets

DOI: 10.2174/1871529x11313020007

Authors: Jerzy Jankun, Ewa Skrzypczak-Jankun

Institution: University of Toledo

Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2417505803

FWCI: 0.717

Cites:

Cited by: 7

Related to: 10